Author:
Yang Ruo-Han,Qin Jia,Cao Jin-Lan,Zhang Ming-Zhu,Li Ying-Ying,Wang Meng-Qing,Fang Dong,Xie Song-Qiang
Subject
Pharmacology,Biochemistry
Reference47 articles.
1. Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway;Longo;N. Engl. J. Med.,2016
2. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy;Sharma;Cell,2017
3. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity;Li;Nat. Commun.,2016
4. High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer;Kuo;Front Med (Lausanne),2022
5. Budimir N, Thomas GD, Dolina JS, Salek-Ardakani S: Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade. Cancer Immunol Res 2022, 10(2):146-153.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献